According to a recent LinkedIn post from Infinity Bio Inc, the company is actively participating in IMMUNOLOGY2026 in Boston, highlighting scientific and networking activities involving its team members. The post notes that Katy Shaw-Saliba, Ph.D., is engaging in a biotech professions networking session and presenting a poster on decoding the antibody reactome at scale using novel antigen display technology.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post also points to a presence on the exhibition floor, with team member Jean-Philippe Laine available at Booth 418 throughout the day. For investors, this visibility at a major immunology conference may indicate efforts to showcase Infinity Bio’s antibody reactomics capabilities, attract talent, and deepen relationships with academic and industry stakeholders, potentially supporting longer-term partnership and pipeline development opportunities.